Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma

We present the results of a phase II trial of carboplatin and etoposide (CE) combination as first-line chemotherapy in patients with recurrent glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) after surgery and radiotherapy. We assess the activity and the tolerability of this combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Franceschi, E, Cavallo, G, Scopece, L, Paioli, A, Pession, A, Magrini, E, Conforti, R, Palmerini, E, Bartolini, S, Rimondini, S, Esposti, R Degli, Crinò, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747702/
https://www.ncbi.nlm.nih.gov/pubmed/15305187
http://dx.doi.org/10.1038/sj.bjc.6602105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747702/
https://www.ncbi.nlm.nih.gov/pubmed/15305187
http://dx.doi.org/10.1038/sj.bjc.6602105

Ejemplares similares